🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

514 results for “Vir” Clear

  1. Entecavir, Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  2. Factor IX Concentrate (purified, virus-inactivated)

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  3. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  4. Fluvirin(TIVf)

    Novartis Pharmaceuticals

    Influenza

    approved mab completed

    1 trial

  5. Ganciclovir

    Hoffmann-La Roche

    Cytomegalovirus Infections

    approved small molecule completed

    1 trial

  6. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  7. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre Fabre Australia Pty Ltd

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  8. H1N1 influenza A Vaccine (Split virion), Inactivated

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  9. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  10. INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN

    The George Institute

    Influenza, Immunity against influenza

    approved small molecule active

    1 trial

  11. IXCHIQ

    Ars Pharmaceuticals Irl Limited

    Chikungunya Virus Infection

    approved mab active

    1 trial

  12. Induction of labor with PGE2

    Guangzhou Virotech Pharmaceutical Co.,

    Labor Induction

    approved small molecule on hold

    1 trial

  13. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  14. Maribavir

    Takeda

    Transplant Complication

    approved small molecule completed

    1 trial

  15. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  16. Nifedipine 30 MG

    Yang I. Pachankis

    Severe Acute Respiratory Syndrome-related Coronavirus

    approved small molecule completed

    1 trial

  17. Quadrivalent Influenza Vaccine (Split Virion), inactivated

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  18. Raltegravir

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    approved small molecule completed

    1 trial

  19. Recombinant Human Adenovirus Type 5 injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  20. Short Cycle Antiretroviral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other completed

    1 trial

  21. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  22. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  23. Sofosbuvir/velpatasvir (Epclusa®)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  24. TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN

    The George Institute

    BK Polyomavirus DNAemia after kidney transplantation

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources